CN1260982A - 入地金牛外用止痛中药 - Google Patents

入地金牛外用止痛中药 Download PDF

Info

Publication number
CN1260982A
CN1260982A CN 99100200 CN99100200A CN1260982A CN 1260982 A CN1260982 A CN 1260982A CN 99100200 CN99100200 CN 99100200 CN 99100200 A CN99100200 A CN 99100200A CN 1260982 A CN1260982 A CN 1260982A
Authority
CN
China
Prior art keywords
chinese medicine
exterior
total
rudijinniu
antalgesic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 99100200
Other languages
English (en)
Inventor
曾永山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 99100200 priority Critical patent/CN1260982A/zh
Publication of CN1260982A publication Critical patent/CN1260982A/zh
Pending legal-status Critical Current

Links

Abstract

入地金牛外用止痛中药是从中药材入地金牛中提取有效部位混入辅料制成膏剂外用,治疗由炎症引起的各种疼痛。

Description

入地金牛外用止痛中药。
本发明涉及的是一种外用止痛中药。
目前，对于入地金牛中药材的使用，一般都是采用水煎汤剂、浸膏或片剂等，以上使用方法由于没把有效成分和杂质分离，口服时容易产生一些副作用；而且传统的使用方法定量也是不科学的。
本发明的目的在于针对上述现有技术的不足，提供一种科学、有效的技术解决方案。
实现本发明关键在于：用化学的方法从中药材入地金牛中分离出总生物碱及总木脂素；分别将总生物碱、总木脂素进一步纯化；用分析仪器分析它们的纯度；按一定比例混入辅料制成膏剂，通过外用皮肤吸收，达到止痛的目的。
经分析总生物碱含有：两面针碱、氧化两面针碱、双氢两面针碱、氯化两面针碱、氧化白屈菜红碱、α-别隐品碱、茵芋碱、6-甲氧基-5，6-双氢白屈菜红碱、6-乙氧基-5，6-双氢白屈菜红碱、木兰花碱、白鲜碱。
总木脂素含有：两面针结晶-8、类细辛素、芝麻脂素。
氯化两面针碱、6-甲氧基-5，6-二氢白屈菜红碱有消炎的作用；茵芋碱、α-别隐碱及总木脂素有很好镇痛作用。
辅料采用水包油型的乳膏基制，外用时更有利于皮肤吸收。
由于采用上述方案，对于炎症引起的各种疼痛使用时只需将本发明的成品药，涂在病发部位的外表皮肤上，5分钟内立即止痛，且消炎的效果非常理想。
实施例：使用本发明的最佳方案，在制药过程中将总生物碱总木脂素按4∶1的比例混入辅料，且剂量为5毫克/克，即总生物碱+总木脂素/辅料+总生物碱+总木脂素。

Claims (2)

1、入地金牛外用止痛中药的其特征在于从中药材入地金牛中分离出总生物碱及总木脂素，定量后将总生物碱及总木脂素按比例混入辅料制成膏剂。
2、根据权力要求1所述的入地金牛外用止痛中药其特征在于它的给药途径是通过皮肤吸收。
CN 99100200 1999-01-19 1999-01-19 入地金牛外用止痛中药 Pending CN1260982A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 99100200 CN1260982A (zh) 1999-01-19 1999-01-19 入地金牛外用止痛中药

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 99100200 CN1260982A (zh) 1999-01-19 1999-01-19 入地金牛外用止痛中药

Publications (1)

Publication Number Publication Date
CN1260982A true CN1260982A (zh) 2000-07-26

Family

ID=5269863

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 99100200 Pending CN1260982A (zh) 1999-01-19 1999-01-19 入地金牛外用止痛中药

Country Status (1)

Country Link
CN (1) CN1260982A (zh)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102861045A (zh) * 2012-09-26 2013-01-09 济南星懿医药技术有限公司 一种治疗神经性疼痛的药物组合物
CN102920726A (zh) * 2012-09-26 2013-02-13 济南星懿医药技术有限公司 一种防治神经性疼痛的药物组合物

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102861045A (zh) * 2012-09-26 2013-01-09 济南星懿医药技术有限公司 一种治疗神经性疼痛的药物组合物
CN102920726A (zh) * 2012-09-26 2013-02-13 济南星懿医药技术有限公司 一种防治神经性疼痛的药物组合物
CN102861045B (zh) * 2012-09-26 2015-06-03 泰山医学院 一种治疗神经性疼痛的药物组合物
CN102920726B (zh) * 2012-09-26 2015-06-03 泰山医学院 一种防治神经性疼痛的药物组合物

Similar Documents

Publication Publication Date Title
CA2301907A1 (en) Treatment of cell-mediated immune diseases
ATE67677T1 (de) Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten.
Keats et al. Analgesic activity and toxic effects of acetylmethadol isomers in man
EP0352025A3 (en) Use of nalmefene in the treatment of allergic rhinitis
CA2530005A1 (en) Use of buprenorphine for the treatment of drug dependence withdrawal in a pregnant woman
EP0906111B1 (en) Composition and method for treating herpes simplex
KR19980014498A (ko) 부자-유황 복합제제
JPH04243825A (ja) 色素沈着症治療剤
CN1088358C (zh) 含有镇咳药和苄达明的镇咳组合物
EP0873125A1 (en) Composition containing diosgenin
CN1260982A (zh) 入地金牛外用止痛中药
KR102610339B1 (ko) 불리아코니틴 에이의 용도
EP0294914A3 (en) Nedocromil for the treatment of dermatological disorders
Brion et al. Evaluation of the antimuscarinic activity of atropine, terfenadine and mequitazine in healthy volunteers.
CN110755580B (zh) 一种具有镇痛作用的中药组合物及其应用
O'Brien et al. A randomized crossover study comparing the efficacy and tolerability of a novel once-daily morphine preparation (MXL® capsules) with MST Continus® tablets in cancer patients with severe pain
CA2076149A1 (en) Potentiation of antitussive effect of dextromethorphan
Simon et al. Administration of obidoxime tablets to man: plasma levels and side reactions
CN102631421A (zh) 一种治疗老年痴呆病的中药
CN1077893A (zh) 丹田健心膏制备方法
JPS6296418A (ja) 薬用チユ−インガム
JPH044300B2 (zh)
RU2188663C1 (ru) Средство для применения в психотерапии психозов, психопрофилактике и бытовой психогигиене, в реабилитации и профилактике рецидивов у больных, перенесших психозы
Rangel-Guerra An open evaluation of oral butorphanol as long-term therapy in out-patients suffering from moderate to severe chronic pain
CN2111768U (zh) 脉冲电场冠脉通治疗仪

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication